Americas
21 January 2025 New president says repeal is first of “many steps the US federal government will take to repair our institutions and our economy” | Defunct order aimed to lower drug costs and place caps on essential medications | Big Pharma argues higher drug prices are necessary to fund R&D for new therapies.
16 January 2025
14 January 2025
17 December 2024
21 November 2024
21 November 2024
Latest Features
Americas
Well-drafted contracts and ironclad tech security can save time and money when an ex-employee steals IP ‘like sugar packets in Starbucks’, finds Tom Phillips.
Americas
Being a lawyer with ADHD is far from easy due to widespread misconceptions about the condition but there are ways to offer support, says Lisa Mueller of Casimir Jones.
Americas
Brazil’s updated regulations for its flagship partnerships programme marks a renewed effort to strengthen the nation's health sector, says Rob Rodrigues of RNA Law.
Americas
An ambiguous decision by the Supreme Court has paved the way for frivolous petitions for compensation and clarity is needed, say Daniel Sanchez and Karla Olvera of Olivares.
Americas
Securing IP protection in Brazil for the ‘bio-ink’ used to print new human tissue has challenges but composition is key, say Priscila Kashiwabara and Breno Souza of Kasznar Leonardos.
Americas
If the right steps are taken, the US International Trade Commission is an attractive option for firms fearing the loss of their valuable IP, say Mary Prendergast, Mark Whitaker and Nicole Ang of Morrison Foerster.
Americas
In part 2 of articles assessing the impact of 'Cellect v Samsung', Vincent Shier of Haynes Boone now sets out what the future may hold—both for this unusual case, as well as judicial doctrine in general.
Americas
A recent precedential case highlights the thorny issue of what constitutes a fair response to new claim constructions following an institution, says Blair Jacobs of McKool Smith.
More News
19 November 2024 Judges at Munich Local Division determined that Meril infringed Edwards Lifesciences’ patent | Meril ordered to stop selling and recall product as well as pay damages.
19 November 2024 Vidal to return to Silicon Valley litigation department and advise on AI issues | Firm is ‘thrilled to welcome Kathi back’ and looking forward to benefitting from her leadership expertise.
14 November 2024 Transatlantic deal would make ‘HSF Kramer’ a top 20 global firm by revenue | ‘Transformational’ combination a ‘one-of-a-kind’ opportunity, say firms’ leaders | HSF Kramer would have 2,700 lawyers, including 640 partners across 25 offices | IP practice would have approximately 32 partners.
7 November 2024 As Donald Trump celebrates a second term, LSIPR looks at how key IP areas could be affected ahead of his return to the Oval Office.
5 November 2024 The 47th US president will need to address the thorny issues of non-competes, patent rights and drug pricing.
31 October 2024 The government’s autumn budget sends a positive signal but a more comprehensive approach is required to unlock the UK’s potential, says Graeme Moore of Mewburn Ellis.
29 October 2024 A federal jury finds Masimo’s smartwatches infringe Apple’s blood oxygen patents | Decision results in an award of just $250 for the tech giant | Despite the victory, Masimo says the ruling does not apply to its current products.
Get up-to-date information on all our publications and events
Get critical life sciences news direct to your inbox